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Our previous results have shown that the parainfluenza virus SV5 is a poor inducer of proinflammatory cytokines interleukin-8 (IL-8) and
macrophage chemoattractant protein 1 (MCP-1). By contrast, an engineered P/V mutant rSV5-P/V-CPI− and a naturally-occurring variant WF-
PIV (Wake Forest–Parainfluenza Virus) are both potent activators of IL-8 and MCP-1. In the present study, we addressed the question of why
rSV5-WT is such a poor inducer of host cytokine responses relative to the two SV5 variants, and we used the CC chemokine RANTES as a
measure of host responses. Time course experiments showed high-level secretion of IL-6 and RANTES following infections of human A549 lung
epithelial cells with the P/V-CPI− mutant and WF-PIV. By contrast, SV5-WT induced very low cytokine responses, with the notable exception of
moderate induction of RANTES. The mechanism of RANTES induction by the two SV5 variants shared common properties, since RANTES
secretion from infected cells had similar kinetics, depended on virus replication, correlated with increased RANTES mRNA levels and promoter
activation, and was reduced by inhibitors of the p38 MAPK, ERK, and PI3K pathways. Despite the similar mechanisms of RANTES induction,
the two SV5 variants differed dramatically in their growth and gene expression kinetics. By comparison to the P/V mutant rSV5-P/V-CPI− which
has accelerated viral gene expression, WF-PIV infection showed a prolonged delay in viral replication, and infected cells did not show high-level
viral RNA and protein expression until ∼12–24 hpi. Sequence analysis revealed that the N, P, V, and M genes from WF-PIV differed by 3, 8, 5,
and 10 amino acids compared to rSV5-WT, respectively. Chimeric viruses harboring the WF-PIV P/Vor M genes in the context of the other rSV5
genes had growth properties similar to rSV5-WT but had a RANTES-inducing phenotype similar to that of the bone fide WF-PIV virus. Our data
indicate a role for both the P/V and the M gene products as determinants of RANTES induction in response to SV5 infection.
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The synthesis of proinflammatory cytokines is a critical arm
of the innate immune response to virus infection that can
contribute to the outcome of an infection, virus tropism, and the
potency of the adaptive immune response (Biron and Sen,
2001). In the respiratory tract, virus-infected epithelial cells are
a major source of a large number of cytokines, including the
type I interferons α and β, chemokines of the CC family such as
macrophage chemoattractant protein-1 (MCP-1) and RANTES
(regulated upon activation, normally T cell expressed and
presumably secreted), and chemokines of the CXC family such
as interleukin-8 (IL-8). Virus-induced cytokines can act on⁎ Corresponding author. Fax: +1 336 716 9928.
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doi:10.1016/j.virol.2006.01.006infected cells through the activation of anti-viral pathways
within the infected cell or in neighboring cells. In addition,
released cytokines can recruit immune cells that infiltrate the
site of infection, thereby aiding in viral clearance as well as the
generation of adaptive immune responses (reviewed in Biron
and Sen, 2001). For example, the chemokine RANTES is a
potent chemoattractant for T cells, monocytes, eosinophils, and
basophils (Bacon and Schall, 1996) and is thought to play a key
role in inflammation observed during some viral infections
(Kujime et al., 2002; Nakamichi et al., 2005; Noe et al., 1999;
Pazdrak et al., 2002).
Many members of the Paramyxovirus family of nonseg-
mented negative strand RNA viruses have been shown to be
potent inducers of cytokine synthesis, including respiratory
syncytial virus (RSV), Sendai virus, human parainfluenza virus
type 2 (HPIV-2), HPIV-3, and Newcastle disease virus (e.g.,
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Young and Parks, 2003; Zhang et al., 2001). RSV infection of
A549 human airway epithelial cells is the best studied model for
Paramyxovirus induction of proinflammatory cytokines (e.g.,
Brasier et al., 1998; Garofalo et al., 1996; Hedges et al., 1995;
Pazdrak et al., 2002). RSV infection of A549 cells induces the
secretion of a large number of interleukins, cytokines, and
chemokines (Casola et al., 2001; Domachowske et al., 2001;
Jamaluddin et al., 2001; Zhang et al., 2001), mimicking the
large cytokine induction seen in vivo that can act to recruit
leukocytes, monocytes, and lymphocytes into the respiratory
tract (reviewed in Hedges et al., 1995; Strieter, 2002).
Type I interferons (IFN) are one of the most important
cytokines induced by virus infection. Many Paramyxoviruses
induce type I IFN but suppress the response to IFN through
accessory proteins (e.g., Andrejeva et al., 2002; Didcock et al.,
1999a, 1999b; Goodbourn et al., 2000; Young et al., 2000). In
contrast, Simian virus 5 (SV5) evades the IFN response through
multiple mechanisms. For example, SV5 counteracts the
cellular IFN signaling pathway by inducing degradation of the
transcription factor STAT1 (Young et al., 2000). The SV5 V
protein, which is expressed from the bicistronic viral P/V gene,
has been shown to be responsible for targeting STAT1 for
degradation (Didcock et al., 1999b). Remarkably, the SV5 V
protein has also been shown to play a role in inhibiting the
induction phase of the IFN response (He et al., 2002; Poole et
al., 2002). SV5-infected human cells show little transcription
from the IFN-β promoter, and translocation of IRF-3 from the
cytoplasm to the nucleus is inhibited following infection with
WT SV5 but not with an rSV5 encoding a V protein that is
truncated (He et al., 2002).
We have previously shown that in addition to limiting IFN
activation, rSV5-WT is also a poor inducer of the host cell
proinflammatory cytokines IL-8 and MCP-1, two cytokines that
are typically associated with Paramyxovirus infections of
respiratory epithelial cells (Young and Parks, 2003; Zhang et
al., 2001). By contrast to rSV5-WT, two SV5 variants have been
previously described as inducers of high levels of proinflam-
matory cytokines such as IL-8 and MCP-1 (Young and Parks,
2003). A recombinant SV5 with engineered substitutions in the
P/V gene (rSV5-P/V-CPI−) directs premature and elevated viral
gene expression (Wansley and Parks, 2002) and induces high
levels of IL-8 secretion (Young and Parks, 2003). In addition, a
naturally occurring SV5 variant (WF-PIV; Wake Forest isolate
of parainfluenza virus) was previously identified as an activator
of proinflammatory cytokine secretion. While the ability of SV5
to limit IFN synthesis and signaling has been studied
extensively, the mechanisms and viral factors that contribute
to the low level of SV5 induction of proinflammatory cytokines
have not been examined.
In the work described here, we hypothesized that the
naturally occurring WF-PIV isolate and the engineered P/V
mutant induced high levels of proinflammatory cytokines by a
shared mechanism in which accelerated and elevated gene
expression results in a high level of gene products that then
induce RANTES secretion. Consistent with this hypothesis,
RANTES induction by the two SV5 variants shared commonproperties: RANTES secretion from infected cells had similar
kinetics, depended on virus replication, correlated with
increased RANTES mRNA levels and promoter activation,
and was reduced by inhibitors of the p38 MAPK, ERK, and
PI3K pathways. However, our results indicate that the two SV5
variants do not share similar growth kinetics or express their
genes to similar levels. Overall, our data indicate that RANTES
induction by the SV5 variants cannot simply be explained by
overexpression of viral gene products. Instead, our results are
consistent with a model in which RANTES is induced by
common gene products synthesized by the rapidly growing P/V-
CPI− mutant and the slow growing WF-PIV variant. The WF-
PIV RANTES-inducing phenotype could be transferred to
rSV5-WT by exchange of genes encoding either the P/V or M
protein. Our data demonstrate a role for both the P/V and the M
gene products as determinants of RANTES induction in
response to SV5 infection.
Results
Gene microarray studies were carried out using Affymetrix
gene chip analysis to identify proinflammatory cytokines that
were differential induced by rSV5-WT and the variants rSV5-P/
V-CPI− and WF-PIV. The related Paramyxovirus HPIV2 was
chosen as a positive control virus that has been shown to be a
potent inducer of proinflammatory cytokines. At 22 hpi of A549
cells, rSV5-WT and rSV5-GFP infections resulted in very little
increase in most proinflammatory cytokine mRNAs (not
shown), consistent with our previous analysis of IL-8 and
MCP-1 induction (Young and Parks, 2003). A notable
exception to this general property of SV5 infections was
found in the case of RANTES, as described in detail below. The
poor induction of host cell cytokine genes by rSV5-WT
contrasted sharply with the high activation of these genes by
HPIV2, as well as the two SV5 variants WF-PIVand rSV5-P/V-
CPI− (not shown). Cells infected with these three viruses
showed elevated mRNA levels for IL-6, IL-8, MCP-1, andMIP-
3 alpha, but TNF-alpha RNA levels were not induced above
background mock-infected samples (not shown). As with rSV5-
WT and rSV5-GFP, RANTES was induced to the highest levels
by infections with the SV5 variants and HPIV2.
To support results from the microarray analysis, a time
course of virus-induced IL-6 and RANTES secretion was
carried out. A549 cells were mock infected or infected with
rSV5-WT, rSV5-P/V-CPI−, WF-PIV, or HPIV2, and at various
times pi, extracellular media were analyzed by ELISA for the
presence of IL-6 or RANTES. In the following experiments,
data for rSV5-WT are shown as an example of the response to
WT virus, since we have previously shown that rSV5-WT and
rSV5-GFP (the proper control for rSV5-P/V-CPI−) are both
very poor cytokine inducers (Young and Parks, 2003). As
shown in Fig. 1, HPIV2 infection resulted in a rapid high-level
secretion of both IL-6 and RANTES that was detected by 4–
8 hpi. A549 cells infected with the two SV5 variants WF-PIV
and rSV5-P/V-CPI− secreted final levels of these cytokines that
were similar to that induced by HPIV2, but the kinetics of IL-6
and RANTES secretion were slower and detectable levels
Fig. 1. IL-6 and RANTES secretion following virus infection. A549 cells were
mock infected or infected at an MOI of 10 with the indicated viruses.
Extracellular media were harvested at the indicated times pi and assayed by
ELISA for IL-6 (A) or RANTES (B). Cytokine levels were normalized to 106
cells. Data are representative of two independent experiments.
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induced from WF-PIV-infected A549 cells with the same
kinetics as IL-6 and RANTES (not shown). Thus, two IRF-3-
dependent host genes (RANTES and interferon-beta) are
induced by the two SV5 variants.
For rSV5-WT, IL-6 levels were very similar to that seen for
mock-infected cells (Fig. 1A), consistent with the hypothesis
that WT virus is a poor inducer of proinflammatory cytokines.
However, RANTES was an exception to this general property.
This is evident in Fig. 1B, where cells infected with rSV5-WT
showed levels of RANTES that were higher than mock-infected
cells, but cytokine secretion appeared only at late times pi and to
levels lower than that seen for the SV5 variants WF-PIV and
rSV5-P/V-CPI−.
Virus-induced RANTES secretion requires virus replication and
correlates with increased RANTES promoter activation
The properties of SV5-induced RANTES secretion were
examined to determine if rSV5-WT activated RANTES through
a mechanism that was distinct or shared with the variants WF-
PIV and rSV5-P/V-CPI−. RANTES induction by WT and
variant SV5 was dependent on virus replication. This is evident
in Fig. 2A, where infection of A549 cells with increasing
amounts of rSV5-WT, WF-PIV, rSV5-P/V-CPI−, or HPIV2
resulted in the secretion of increased amounts of RANTES by
24 hpi. SV5-induced RANTES secretion was also dependent oninfection with live virus, since RANTES was not induced
following infection with UV-treated virus (Fig. 2B).
Cytokine secretion can be induced through increased
cytokine mRNA or by regulation of protein synthesis or
mRNA stability. To distinguish between these possibilities,
virus-induced RANTES mRNA accumulation was assayed by
real-time PCR. As shown in Fig. 2C, HPIV2 infection induced
early high levels of RANTES mRNA detectable by 8 hpi.
Infection with the SV5 variants rSV5-P/V-CPI− and WF-PIV
induced lower levels of RANTES mRNA at early times pi, but
by 24 hpi cells infected with the P/V mutant had the highest
levels of RANTES mRNA. Lower levels of RANTES mRNA
accumulated at late times after infection with rSV5-WT.
A transfection/infection assay was carried out to determine if
the increased accumulation of virus-induced RANTES mRNA
correlated with increased RANTES promoter activation. A549
cells were transfected with a plasmid encoding luciferase under
control of the minimal RANTES promoter (Casola et al., 2001).
Cells were then mock infected or infected at high MOI with
rSV5-WT, P/V-CPI−, WF-PIV, or HPIV2. As shown in Fig. 2D,
the P/V-CPI− mutant and WF-PIV induced the highest
RANTES promoter activation, while rSV5-WT-infected cells
had much lower levels of luciferase activity. Promoter
activation by virus infection was much lower when cells were
transfected with a plasmid containing luciferase under control of
a RANTES promoter from which the critical ISRE regulatory
element had been deleted (Fig. 2D). This result is similar to the
previously described requirement for the ISRE site in RSV-
induced RANTES secretion from A549 cells (Casola et al.,
2001). Taken together, these data indicate that infection with
rSV5-WT, the two SV5 variants P/V-CPI− and WF-PIV, and
HPIV2, results in RANTES promoter activation and a
corresponding increase in RANTES mRNA accumulation.
Previous work with RSV, influenza virus, and rabies virus
has shown a role for MAPK activation in the control of
RANTES secretion (Guillot et al., 2005; Kujime et al., 2002;
Nakamichi et al., 2005; Pazdrak et al., 2002). To determine if
RANTES secretion induced by rSV5-WT, rSV5-P/V-CPI−, or
WF-PIV was dependent on p38 MAPK activation, A549 cells
were infected in the presence of increasing amounts of the p38
inhibitor SB202190 (Fig. 3A). Addition of 50 μM inhibitor
resulted in RANTES secretion that was significantly decreased
relative to the control samples for rSV5-WT, rSV5-P/V-CPI−,
and WF-PIV infections. A similar requirement for ERK
signaling in virus-induced RANTES secretion was found
following infection of A549 cells with WT and variant SV5,
since infection in the presence of the MEK1/MEK2 inhibitor
U0126 resulted in significant decreases in RANTES secretion
for each virus infection at a concentration of 50 μM (Fig. 3B).
RANTES secretion from influenza virus-infected bronchial
epithelial cells has been shown to also be dependent on
phosphatidyl-inositol-3-kinase (PI3K) activity (Guillot et al.,
2005). As shown in Fig. 3C, addition of increasing concentra-
tions of the PI3K inhibitor LY294002 to virus-infected A549
cells resulted in a significant dose-dependent decrease in
RANTES secretion. These data are similar to results on the
mechanism of influenza-induced RANTES secretion from
Fig. 2. Virus infection results in increased activation of RANTES promoter and accumulation of RANTES mRNA. (A) MOI-dependent RANTES secretion. A549
cells were infected with increasing MOI of virus, and media were analyzed for RANTES secretion by ELISA. Cytokine levels were normalized to 106 cells. (B)
RANTES secretion requires virus replication. A549 cells were infected with live (control) or UV-treated virus, and extracellular media were harvested at 24 hpi and
analyzed by ELISA for RANTES. Data are representative of two independent experiments. (C) Accumulation of RANTES mRNA. Total RNAwas harvested from
mock-infected or infected A549 cells (MOI of 10) at the indicated times pi and analyzed by real-time PCR for the presence of RANTES mRNA as described in
Materials and methods. Data are representative of three independent experiments. (D) RANTES promoter activation. A549 cells were co-transfected with pSV-βgal
along with plasmids containing the luciferase gene under control of the WT RANTES promoter or a promoter in which the ISRE has been deleted (ISRE mut). Cells
were then infected at 24 h post-transfection at an MOI of 10 and 24 h later cell lysates were analyzed for luciferase levels as an indication of RANTES promoter
activity. Luciferase levels were normalized to β-galactosidase levels to normalize for transfection efficiency. Data are representative of three independent experiments.
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with a role for p38-, ERK-, and PI3K-dependent pathways in
RANTES secretion induced by rSV5-WT, rSV5-P/V-CPI−, and
WF-PIV. Interestingly, HPIV2-induced RANTES secretion was
not significantly diminished by increasing amounts of the p38,
ERK, and PI3K inhibitors (Figs. 3A–C). Taken together, these
data indicate that the two SV5 variants induce RANTES
secretion through common mechanisms and pathways which
may be distinct from that induced by HPIV2 infection.
Delayed viral gene expression in cells infected with WF-PIV
The above results indicate that the two SV5 variants rSV5-P/
V-CPI− and WF-PIV induce A549 cells to secrete RANTES
through a similar mechanism and with very similar kinetics.
rSV5-P/V-CPI− is an engineered mutant containing six
naturally occurring substitutions in the P/V gene and has been
shown to have accelerated kinetics of virus growth and gene
expression relative to rSV5-WT (Wansley and Parks, 2002;
Wansley et al., 2003). WF-PIV is a naturally occurring SV5
variant whose growth and gene expression properties have not
been reported. Based on the similar mechanisms of RANTESinduction by rSV5-P/V-CPI− and WF-PIV, we hypothesized
that WF-PIV would also display accelerated kinetics of growth
and gene expression relative to rSV5-WT.
Single-step growth kinetics of rSV5-WT and WF-PIV
revealed that this hypothesis was incorrect. In contrast to the
rapidly growing rSV5-WT, two independently plaque-purified
stocks of WF-PIV failed to produce significant levels of
progeny virus until after 24 hpi (Fig. 4A). In Western blot
analysis, cells infected with rSV5-WT showed the accumulation
of detectable viral N and P by 8 hpi, with high levels of these
proteins plateauing by ∼24 hpi (Fig. 4B). By contrast, WF-PIV
N and P were not detected at high levels until ∼24 hpi. By this
time point, WF-PIV N and P had accumulated to similar levels
to that seen in rSV5-WT-infected cells at ∼8–12 hpi. Delayed
protein accumulation was seen for all WF-PIV gene products
(not shown). Cells infected with WF-PIValso showed a delay in
reaching a high rate of viral protein synthesis. This is evident in
Fig. 4C, where pulse-labeling of infected A549 cells with 35S-
amino acids showed a maximum rate of N protein synthesis for
rSV5-WT between 8 and 12 hpi, and this was followed by a
decreased rate of synthesis at later times pi, as reported
previously (Young et al., 2001). By contrast, WF-PIV-infected
Fig. 3. RANTES secretion in the presence of MAPK, ERK, and PI3K inhibitors.
A549 cells were pretreated for 1 h and infected in the presence of increasing
amounts of inhibitors of the p38 MAPK (A; SB202190), MEK1/2 (B; U0126),
or PI3K (C; LY294002). At 24 hpi, extracellular media were harvested and
analyzed for RANTES by ELISA. Cytokine levels were normalized to 106 cells.
Data are representative of two independent experiments. *Denotes P b 0.001 and
++ denotes P b 0.01 relative to control treated samples using Student's t test.
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Likewise, the rate of synthesis of P and V was delayed for WF-
PIV compared to rSV5-WT (Fig. 4D). Similar results were
obtained in Vero cells (data not shown), indicating that the delay
in abundant viral gene expression was not due to antiviral
effects of IFN.
The above delayed viral gene expression was not due to a
low number of cells infected by WF-PIV. This is evident in Fig.
4E where nearly all cells in the population were infected with
WF-PIV at an MOI of 10 as assessed by indirect immunofluo-
rescence. Consistent with data in Figs. 4B and C, indirect
immunofluorescence also revealed lower levels of N protein in
WF-PIV-infected cells relative to WT rSV5-infected cells.
The levels of Paramyxovirus proteins are thought to be
largely determined by levels of viral transcription (Lamb and
Kolakofsky, 2001). Real-time PCR assays were carried out todetermine if the relative delay in abundant WF-PIV viral protein
expression was also seen at the level of viral mRNA
accumulation. Total RNA was harvested from cells at various
times pi with rSV5-WT or WF-PIV and used in a first strand
synthesis reaction using oligo-dT primers. The resulting cDNAs
were analyzed by real-time PCR for the presence of N and M
viral mRNAs. As shown in Fig. 5A, rSV5-WT-infected cells
accumulated N and M mRNA in a time-dependent manner with
mRNA levels peaking at 12 hpi. In contrast, WF-PIV-infected
cells accumulated N and M mRNA with delayed kinetics in
which mRNA accumulation peaked at 24 hpi, indicating that the
WF-PIV delay in protein synthesis and accumulation correlated
with viral mRNA accumulation. As shown in Fig. 5B, this delay
in WF-PIV mRNA accumulation also occurred in interferon-
deficient Vero cells and in BHK cells (not shown), a cell line
that does not respond to type I IFN. These results indicate that
the lag in WF-PIV gene expression cannot be attributed to a
virus-induced IFN response.
To determine if the WF-PIV delay in gene expression was
occurring at the stage of primary transcription, A549 cells were
infected with rSV5-WT or WF-PIV in the presence or absence
of the translation inhibitor cycloheximide, and mRNA accu-
mulation was measured by RT-PCR. By inhibiting translation,
the switch from primary transcription to replication is blocked,
and only primary transcripts accumulate in the infected cells
(Lamb and Kolakofsky, 2001). As shown in Fig. 5C, rSV5-WT-
infected cells accumulated about 2-fold more N mRNA by 6 hpi
in the absence of cycloheximide than did corresponding WF-
PIV-infected cells. However, in the presence of cycloheximide,
N primary transcripts accumulated to approximately equivalent
levels between rSV5-WT and WF-PIV-infected cells. These
data indicate that the delay in WF-PIV gene expression occurs
at a step in virus replication that is downstream of primary
transcription, such as genome replication or secondary
transcription.
Role of the WF-PIV 3′ end genes in delayed viral gene
expression and RANTES induction
The Paramyxovirus 3′ end genes are important determi-
nants of both viral replication and the control of host antiviral
responses (Lamb and Kolakofsky, 2001). We tested the
hypothesis that the WF-PIV 3′ end genes encoding N, P/V,
and M contributed to both the delay in WF-PIV gene
expression and virus-induced RANTES expression. RT-PCR
was used as described in Materials and methods to clone and
sequence 4478 bases of WF-PIV genome sequences that
spanned from immediately downstream of the N start site
through the P/V gene and up to the M gene 3′ end region.
Consensus nucleotide sequences for the N, P/V, and M genes
were generated by analysis of cDNA clones derived from
multiple RT-PCR experiments. Fig. 6 summarizes the amino
acid differences between rSV5-WT and WF-PIV N, P, V, and
M proteins.
While the WF-PIV N gene had 43 nucleotide changes
compared to rSV5-WT, these translated to only 3 amino acid
differences, all located in the C-terminal half of N (Fig. 6A).
Fig. 4. WF-PIV has delayed growth and gene expression properties compared to rSV5-WT. (A) Single-step growth kinetics of two independently plaque-purified
stocks of WF-PIV relative to rSV5-WT. (B) Viral protein accumulation. A549 cells were mock infected (lane M) or infected at an MOI of 10 with rSV5-WT or WF-
PIV. Cell lysates prepared at the indicated times pi were analyzed by Western blotting for viral proteins N and P. Exposure times were the same between panels. (C and
D) Rate of viral protein synthesis. A549 cells were infected at an MOI of 10 with rSV5-WTor WF-PIVand at the indicated times pi were pulsed with [35S]-Trans label
for 30 min. Lysates were immunoprecipitated with polyclonal sera raised to SV5 N protein (C) or a monoclonal antibody to the common region of the P and V proteins
(D) and analyzed by SDS-PAGE and autoradiography. M lane at 8 hpi is from mock-infected cells. (E) Immunofluorescence. A549 cells were mock infected or
infected at an MOI of 10 and at 12 hpi cells were fixed, permeabilized with saponin, and analyzed for N protein levels by indirect immunofluorescence microscopy.
Data in panels A–E are representative of at least three independent experiments.
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conserved among Paramyxovirus N protein sequences (Lamb
and Kolakofsky, 2001). The WF-PIV P/V gene had 20
nucleotide changes compared to rSV5-WT, resulting in
8 amino acid changes in the P open reading frame (Fig. 6A).
Within the M gene, WF-PIV had 37 nucleotide differences
compared to rSV5-WT, resulting in 10 predicted amino acid
changes scattered throughout the M protein. The recently
identified SV5 late domain virus budding motif identified by
Schmitt et al. (2005) was maintained at positions 20-FPIV-23 of
the WF-PIV M protein, suggesting that the delayed growth of
WF-PIV could not be solely attributed to a defect in this step of
virus assembly.
Differences in the V protein of the W3A strain of SV5 and
WF-PIV were of particular interest, since this is a multifunc-
tional protein involved in controlling viral gene expression
(Horikami et al., 1996; Lin et al., 2005; Randall and
Bermingham, 1996), as well as host antiviral responses (Poole
et al., 2002; Sun et al., 2004; Wansley et al., 2003). As shown in
the alignment in Fig. 6B, the C-terminal Cys-rich region of the
WF-PIV V protein contained no predicted amino acid changes,
while the shared P/V N-terminal region had 5 predicted amino
acid changes relative to W3A SV5.To determine the contribution of the 3′ end genes of WF-
PIV to the delayed gene expression kinetics and the induction
of RANTES, a recombinant SV5 chimeric virus was generated
such that the coding and noncoding regions of the WF-PIV N,
P/V, and M genes were substituted into an rSV5-GFP
background to generate rSV5-NPM-WF. The resulting rSV5-
WF chimera was assessed for its single-step growth kinetics
and gene expression profile compared to the control WT
rSV5-GFP. As shown in Fig. 7, single-step growth analysis of
rSV5-NPM-WF showed that the chimeric virus had similar
growth kinetics to that of rSV5-GFP, with slightly higher
growth seen at early times pi. Similarly, microscopy and
Western blot analyses (Figs. 7B and C, respectively) showed
equivalent or slightly higher protein expression for cells
infected with rSV5-NPM-WF relative to that of rSV5-GFP.
Thus, the changes within the 3′ end 4478 bases of the WF-
PIV genome cannot by themselves account for the delay in
growth and gene expression seen in infections with the bone
fide WF-PIV virus.
Extracellular media harvested from cells infected with the
rSV5-NPM-WF chimera showed elevated RANTES secretion
compared to cells infected with WT rSV5-GFP, and these
levels were very similar to that seen with the bone fide WF-
Fig. 5. Accumulation of WF-PIV mRNA is delayed compared to rSV5-WT-infected cells. (A) Kinetics of mRNA accumulation. A549 cells were infected at an MOI of
10 with WF-PIVor rSV5-WT and at the indicated times pi, total RNAwas harvested and analyzed by real-time PCR as described in Materials and methods for the
presence of viral N andMmRNA. Data are the mean plus standard deviation from three independent experiments. (B) mRNA accumulation in IFN-negative Vero cells.
Levels of N mRNAwere determined as described in Materials and methods at 8 and 24 hpi of Vero cells with rSV5-WT and WF-PIV. Data are representative of three
independent experiments. (C) Accumulation of mRNA during primary transcription. A549 cells were infected at an MOI of 10 in the presence or absence of 100 μg/ml
cycloheximide. At the indicated times pi, total RNAwas harvested and analyzed by real-time PCR for the presence of N viral mRNA sequence. Data are representative of
three independent experiments.
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from cells infected with rSV5-NPM-WF were always less
than that seen with WF-PIV-infected cells, these differences
were not statistically significant. Thus, the rSV5-NPM-WF
chimeric virus which contains the WF-PIV N, P/V, and M
genes has growth and gene expression properties similar to
rSV5-WT but has a RANTES-inducing phenotype similar to
that of WF-PIV.Fig. 6. Sequence analysis of WF-PIV N, P/V, and M genes. (A) The amino acid dif
amino acids are indicated above the box and WF-PIV residues below the box. (B) Al
and the SV5 isolate CPI minus. Amino acid changes relative to W3A sequence areTo test the individual contribution of the WF-PIV P/Vand M
genes in RANTES induction, two additional chimeric viruses
were constructed such that the WF-PIV P/V gene alone (rSV5-
P/V-WF) or the M gene alone (rSV5-M-WF) was inserted in the
context of the remaining rSV5-GFP genes. Both chimeric
viruses grew to titers that were as high or higher than that of the
WT control rSV5-GFP in single-step growth assays (Fig. 8A).
A549 cells infected with the P/V-WF or the M-WF chimericferences between WF-PIV N, P, and M proteins relative to rSV5-WT. SV5-WT
ignment of V protein amino acid differences between WT SV5 (W3A), WF-PIV
shown beneath each position.
Fig. 7. Growth properties, gene expression, and RANTES induction by the chimeric rSV5-NPM-WF virus. (A) Single-step growth analysis. A549 cells were infected
with rSV5-NPM-WF (NPM) or rSV5-GFP and virus titers determined at the indicated times pi. Data are the mean values from two independent experiments. (B) GFP
expression. A549 cells were infected at an MOI of 10 and at 12 and 24 hpi, cells were visualized by microscopy. (C) Time course of viral protein accumulation. A549
cells were mock infected or infected at an MOI of 10 and lysates prepared at the indicated times pi. Equivalent amounts of protein were analyzed by Western blotting
for the viral protein P. Data are representative of three independent experiments. (D) RANTES induction. Extracellular media were harvested from infected A549 cells
(MOI of 10) at 12 or 36 hpi and analyzed for RANTES by ELISA. ++ Denotes P b 0.01 relative to control rSV5-GFP samples using Student's t test. Values for WF-PIV
and NPM samples were not significantly different.
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the rSV5-NPM-WF chimera which contains the WF-PIV N, P/
V, and M genes (Fig. 8B) and slightly less that that seen for the
bone fide WF-PIV parental virus (not shown). Together, these
date indicate that the P/V and M genes of WF-PIV can
individually contribute to RANTES induction, at least when
expressed in the context of the other rSV5-WT genes.Fig. 8. Growth properties and RANTES induction by the chimeric rSV5-P/V-WF and
at an MOI of 10 with rSV5-GFP, rSV5-P/V-WF (P/V), or rSV5-M-WF (M) and virus t
assays. (B) RANTES induction. Extracellular media were harvested at 36 hpi from A
of RANTES by ELISA. Data are the mean plus standard deviation from one of two in
determined by Student's t test. Values for P/V, M, and NPM samples were not signiDiscussion
The activation of proinflammatory cytokine expression
following virus infection is an important host cell response
that can limit virus growth and promote adaptive immunity. The
viral factors that determine whether a Paramyxovirus induces or
limits host cell cytokine responses are not completelyrSV5-M-WF viruses. (A) Single-step growth analysis. A549 cells were infected
iters determined at 36 hpi. Values are the mean plus standard deviation from three
549 cells infected with the indicated viruses (MOI of 10) and analyzed for levels
dependent experiments. *Denotes P b 0.01 relative to control rSV5-GFP samples
ficantly different.
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previous findings: rSV5-WT is a poor inducer of IL-8 and
MCP-1, and the SV5 variants rSV5-P/V-CPI− and WF-PIV
induce high levels of IL-8 (Young and Parks, 2003). We have
addressed the question of why rSV5-WT is such a poor inducer
of host cytokine responses relative to the two SV5 variants.
Based on the similar kinetics and mechanisms of RANTES
induction by the two variants, we initially hypothesized that an
accelerated expression of viral gene products by rSV5-P/V-CPI−
and WF-PIV was the basis for induction of RANTES. As
described below, our results on the mechanism of differential
cytokine induction by WT and variant SV5 viruses support four
conclusions: (1) wild-type SV5 is an overall poor inducer of
most cytokine responses in A549 lung epithelial cells, with the
exception of RANTESwhich is secreted from infected cells only
at moderate levels and at late times pi, (2) the SV5 variants rSV5-
P/V-CPI− and WF-PIV activate expression of a number of
cytokines and share common features in the pathways and
mechanisms of RANTES induction, (3) the kinetics of viral gene
expression relative to rSV5-WT differ dramatically for the rSV5-
P/V-CPI− mutant with accelerated gene expression and the
naturally occurring WF-PIV variant with delayed gene expres-
sion, and (4) rSV5-WT can be converted into a more potent
inducer of RANTES by introduction ofWF-PIV sequences from
either the P/V gene or the M gene, but these genes do not confer
the WF-PIV phenotype of delayed viral gene expression.
Together, our data suggest that regardless of expression levels,
gene products expressed by the SV5 variants are either inherent
inducers of RANTES or are defective suppressors of the
RANTES response.
We have focused our mechanistic studies on RANTES, a
well-characterized cytokine response to virus infections in
A549 cells (Casola et al., 2001 and references therein). Virus-
induced transcription from the RANTES promoter requires
IRF-3 and is dependent on an ISRE in the promoter (Casola et
al., 2001; Genin et al., 2000; Lin et al., 1999). Previous work on
the cis-regulatory elements controlling RSV-induced RANTES
promoter activity in A549 cells has shown that the ISRE does
not bind a STAT complex, but instead, IRF-3 is the major
transactivating factor that binds this element in response to
infection (Casola et al., 2001). Similarly, Lin et al. have shown
that the STAT complex interferon-stimulated gene factor 3
(ISGF3) did not play a role in the induction of RANTES in 293
cells infected with Sendai virus nor did IRF-1 or IRF–7 largely
contribute to RANTES activation following Sendai virus
infection (Lin et al., 1999).
Why are WF-PIV and the P/V-CPI− mutant potent inducers
of proinflammatory cytokines whereas rSV5-WT generally
limits cytokine production? We have shown here that the two
variant viruses activate RANTES secretion through similar
replication-dependent mechanisms and with similar kinetics;
therefore, we proposed a hypothesis that the P/V-CPI− mutant
and WF-PIV may share a common phenotype of accelerated
viral gene expression (Wansley et al., 2005) and may activate
a host cell cytokine response before a viral antagonist could
effectively block host responses. Our results here demonstrate
that contrary to our hypothesis, WF-PIV has a remarkabledelay in high-level viral replication and gene expression
relative to both rSV5-WT and the P/V-CPI− recombinant. The
exchange of WF-PIV N, P/V, and M genes into the
background of rSV5-WT produced a chimeric virus rSV5-
NPM-WF that had growth and gene expression properties that
were equal to or slightly higher than rSV5-WT and much
higher than the bone fide WF-PIV. Thus, the WF-PIV N, P/V,
and M genes are not solely responsible for the dramatic
differences in replication kinetics between rSV5-WT and
WF-PIV. The WF-PIV L gene and leader are alternative can-
didate genes that may contribute to delayed viral gene ex-
pression, and work is in progress to identify determinants of
replication kinetics within these viral genes. However, the
rSV5-NPM-WF chimeric virus as well as the P/V-WF and
M-WF viruses showed reproducibly higher induction of
RANTES compared to rSV5-WT, indicating that these viruses
had similar replication kinetics but different cytokine inducing
phenotypes.
The outcome of whether cytokine responses are activated
by a virus infection can be viewed as a combination of the
level or type of viral components that act as inducers and the
ability of a virus to actively block the cellular response (Biron
and Sen, 2001; Goodbourn et al., 2000). Our data on the two
SV5 variants with similar mechanisms of RANTES induction
but dissimilar gene expression and growth profiles (Wansley
and Parks, 2002; Figs. 4, 5) suggest that in our model system,
it is not the level of viral components that activate the host
response but rather the type of viral component. We propose
two nonexclusive models to explain why the naturally
occurring WF-PIV, the engineered rSV5-P/V-CPI−, and the
chimeric rSV5-NPM-WF viruses induce higher levels of host
cell responses compared to rSV5-WT. In the first model, the
SV5 variants induce cytokines either by producing a different
inducer than WT SV5 or a common inducer is produced at
levels that are higher than rSV5-WT. The 3′ end genes of
other negative strand RNA viruses have been shown to be
important activators of host response, specifically IRF-3
activation. For example, IRF-3 can be activated by transcrip-
tion of the Measles virus N gene outside of the context of a
viral infection (Noe et al., 1999) or by purified VSV
ribonucleoprotein complexes (TenOever et al., 2004). The
three of the four SV5 variants that have high RANTES
induction (WF-PIV; rSV5-P/V-CPI−; NPM-WF; and P/V-WF)
contain differences in the P/V gene compared to rSV5-WT.
Substitutions in the P protein, a multifunctional component of
the viral RNA-dependent RNA polymerase (Horikami et al.,
1992), could make the polymerase complex more prone to
synthesize dsRNA, a known activator of host cell responses
leading to RANTES induction (Rudd et al., 2005). Interest-
ingly, an additional chimera containing an exchange of the M
gene alone (rSV5-M-WF) was equally potent at RANTES
induction compared to the other chimeras, indicating that viral
components expressed from the M gene can also act directly
or indirectly as determinants of host cell cytokine responses to
Paramyxovirus infection.
A second model for differential cytokine induction
proposes that a common inducer is produced by the WT and
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activation of the host response. It has been previously shown
that the V protein of WT SV5 plays a role in counteracting
host IFN responses by targeting signal transducer and activator
of transcription 1 (STAT1) for degradation, as well as by
preventing the translocation of IRF-3 to the nucleus in
response to dsRNA stimulation (Andrejeva et al., 2002;
Didcock et al., 1999a, 1999b; He et al., 2002; Poole et al.,
2002). These results not only provide evidence for V protein
acting as an antagonist of the host IFN response, but they also
suggest that V protein should be an important antagonist of
RANTES induction since RANTES induction following viral
infection is IRF-3-dependent (Casola et al., 2001; Lin et al.,
1999). Three of the cytokine-inducing variants contain
substitutions in the V protein compared to WT SV5, and it
is possible that these altered V proteins are less effective at
counteracting IRF-3 activation. Future work will define the
role of P and V proteins in inducing and counteracting
RANTES activation as well as other proinflammatory cytokine
responses.
While rSV5-WT is a poor inducer of type I interferon (He
et al., 2002; Poole et al., 2002; Wansley et al., 2003) as well as
many other prototype proinflammatory cytokines, an unex-
pected finding was the moderate induction of the IRF-3-
dependent gene encoding RANTES at late times pi (Figs. 1–
3). Previous results have shown that the V protein of WT SV5
prevents the translocation of IRF-3 to the nucleus (He et al.,
2002; Poole et al., 2002), contributing to the low level
induction of IFN-β even at late times following WT virus
infection. If IRF-3 translocation is blocked by the SV5 V
protein, then why does rSV5-WT virus activate moderate
expression of RANTES, an IRF-3-dependent gene? A simple
explanation is that RANTES may be more sensitive to low
levels of IRF-3 activation than other IRF-3-dependent genes.
Alternatively, differences between the very low level induction
of IFN-β and the moderate induction of RANTES by WT
virus infection may reflect differences in the requirement of
these genes for IRF-3 alone or in combination with other
factors such as NF-κB and AP-1. Spann et al. described an
early activation of IRF-3 following infection with both wild-
type RSV (wt RSV) and RSV deletion mutants lacking the
IFN antagonist proteins NS1 and NS2. However at later times
pi, nuclear IRF-3 was still detected in cells infected with the
deletion mutants but not in wt RSV-infected cells, resulting in
dramatic differences in the duration of the host response to wt
RSV and mutant virus infections (Spann et al., 2005). These
findings suggest that early in infection, prior to accumulation
of a viral inhibitor to sufficient levels, some viruses initially
activate a host response but then subsequently downregulate
the host response once viral inhibitor has accumulated to
sufficient levels. However, this model is inconsistent with our
finding of RANTES mRNA accumulation and secretion of
RANTES protein only at late times following rSV5-WT
infection (Figs. 1B, 2C).
An alternative model for rSV5-induction of RANTES is
based on the proposal that the rate and level of growth and gene
expression plays a role in the balance between limiting versusactivating host cell responses. This is supported by previous
work showing that cytokine induction was associated with a
rapid virus growth profile for a pathogenic isolate of West Nile
virus (WNV), and IRF-3-dependent genes were turned on at late
times pi (Fredericksen et al., 2004). Thus, the appearance of
RANTES at late times pi with rSV5-WT may reflect a high rate
of virus growth that eventually overwhelms the V-imposed
block on IRF-3-dependent gene transcription.
The three viruses rSV5-WT, rSV5-P/V-CPI−, and WF-PIV
shared a common mechanism of RANTES induction in which
the RANTES promoter is activated through a replication-
dependent pathway that could be blocked by p38 MAPK,
ERK, and PI3K inhibitors. These data are consistent with
previous results that identified MAPK and/or PI3K pathways
in RANTES secretion induced by infection with RSV, rabies
virus, and influenza virus (Kujime et al., 2002; Nakamichi et
al., 2005; Pazdrak et al., 2002). The requirement for p38
MAPK, ERK, and PI3K could reflect signal transduction
pathways that upregulate RANTES transcription or that result
in stabilization of RANTES mRNA as shown previously for
IL-8, IL-6, and RANTES activation in HeLa cells (Casola et
al., 2001; Holtmann et al., 1999; Winzen et al., 1999).
Infection with rSV5-WT or the SV5 variants results in
transcriptional activation of the RANTES promoter, but
additional roles for the MAPK signaling cascades in SV5-
induced stabilization of RANTES mRNA are currently being
tested.
Determining the molecular basis for the activation of host
responses following viral infection is required for a better
understanding of factors that impact pathogenesis. In addition,
as viruses are engineered for therapeutic use, it will be of great
importance to determine the impact of attenuating mutations
and gene substitutions on virus-induced innate immune
responses.
Materials and methods
Cells, viruses, growth analysis, and plaque assays
Monolayer cultures of cells were grown in Dulbecco's
modified Eagle's medium (DMEM) containing 10% fetal
bovine serum (FBS). W3A strain of SV5 and the Greer strain
of HPIV2 were grown in MDBK and CV-1 cells, respectively.
WF-PIV and the rSV5-NPM-WF chimera were grown in Vero
cells. WF-PIV was plaque purified from media derived from
persistently infected Vero cells kindly provided by Steve
Krakowa (The Ohio State University). Plaque-purified virus
was grown under low MOI conditions. rSV5-GFP virus was
recovered from cDNA which was the kind gift of Biao He and
Robert Lamb (Northwestern University). Single-step growth
assays were carried out as described previously (Wansley and
Parks, 2002).
For inactivation of virus by UV treatment, viruses diluted in
DMEM/10% BSA were held in 60-mm dishes for 20 min
under a handheld germicidal ultraviolet (UV) lamp at a
distance of 6.5 cm. This procedure eliminated all infectivity as
determined by plaque assays. When MAPK and phosphatidyl
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pretreated with the indicated inhibitor concentrations (or
DMSO solvent for control samples) for 1 h and were then
infected in the presence of inhibitor.
Sequence analysis of WF-PIV 3′ end genes and construction of
chimeric virus
For cloning of viral genes, nucleocapsid RNA was isolated
from WF-PIV-infected Vero cell lysates by banding on cesium
chloride gradients followed by Trizol extraction. Reverse
transcriptase PCR (RT-PCR) reactions were carried out with
SV5-specific primer pairs spanning overlapping regions of the
3′ end genes and resulting products were cloned into pCR4-
TOPO vectors (Invitrogen). Multiple clones from multiple RT-
PCR reactions were used to obtain consensus sequence data for
the WF-PIV genomic RNA bases 19–4460. Plasmids encoding
the consensus sequences were assembled from PCR products
using available restriction sites.
Chimeric recombinant viruses harboring the WF-PIV N, P/V,
and M genes alone (rSV5-P/V-WF and rSV5-M-WF) or in
combination (rSV5-NPM-WF) were constructed using standard
molecular biology techniques (Parks et al., 2001; details
available upon request) by insertion of an NdeI-Asp718
fragment spanning from the 5′ end of the N gene to the 3′
end of the M gene into pBH311 (He et al., 1997). Viruses were
recovered as described previously (Wansley and Parks, 2002).
The presence of WF-PIV genes was confirmed by sequencing
RT-PCR products derived from infected cell RNA.
Western blotting and isotopic labeling of polypeptides
For Western blotting, the protein concentration of cell lysates
was determined by BCA assay (Pierce Chemicals), and
equivalent amounts of protein were analyzed with rabbit
antisera to the SV5 N or P proteins (Parks et al., 2001) followed
by HRP-conjugated secondary antibodies and ECL. Mock-
infected or virus-infected A549 cells were radiolabeled for 20
min at 24 h post-infection (pi) using 200 μCi/ml Tran[35S]-
label. Cells were lysed in 1% SDS and samples immunopre-
cipitated using anti-N antibodies or a monoclonal antibody to
the common region of the P and V proteins (V5 antibody;
Invitrogen) as described previously (Parks et al., 2001).
Enzyme-linked immunosorbent assay
Immunoreactive IL-6 or RANTES in extracellular media
was quantitated by a dual antibody sandwich ELISA (DuoSet;
R&D Systems, Inc.). To allow comparisons between experi-
ments, cytokine levels were determined for the number of cells
at the time of infection, and values were normalized to 106 cells.
Analysis of transcription products
To measure the accumulation of viral mRNA, total RNAwas
isolated from mock-infected or virus-infected A549 cells at the
indicated times pi using Trizol (Invitrogen). RNA was reversetranscribed with MMLV-RT and oligo-dT primer, and a portion
of the resulting cDNAs was used in a real-time PCR assay using
an ABI Prism 7000 with primer/probe sets designed to detect
cellular actin, SV5 N, or SV5 M mRNA. N and M primer/probe
sets were designed to anneal within sequences that were
conserved between WF-PIV and SV5 and are available upon
request. To determine the levels of primary transcripts in
infected cells, A549 cells were or were not treated with 100 μg/
ml cycloheximide during and following infection. At the
indicated times post-infection, total RNA was harvested and
analyzed for viral mRNA levels as described above.
Reporter gene assays
Induction of the RANTES promoter was assayed using
pGL2-220, a plasmid containing the luciferase reporter gene
downstream of 220 bases from the human RANTES regulatory
region, defined by Casola et al. (2001) as being the minimal
RANTES promoter fragment that retains full RSV inducibility.
The ISRE mutant form of this construct (pGL2-120) was
modified to lack the ISRE of the RANTES promoter (Casola et
al., 2001). Both plasmids were the kind gift of Dr. Alan Brasier
(University of Texas Medical Branch). The pSV-βgal plasmid
(Promega) consists of the β-galactosidase gene under the
control of a constitutive SV40 promoter and was used to
normalize for transfection efficiencies between samples. Six-
well dishes of A549 cells were co-transfected with 1 μg pSV-
βgal and 3 μg pGL2-220 or pGL2-120 per well using the
calcium phosphate transfection protocol. Twenty-four hours
post-transfection, cells were mock infected or infected with live
or UV-treated rSV5-WT, rSV5-P/V-CPI−, WF-PIV, or HPIV2.
Cells were harvested in reporter lysis buffer (Promega) at
indicated times pi, and luciferase and β-galactosidase activities
were determined. Normalized luciferase activity was calculated
as luciferase activity divided by β-galactosidase activity.
Microscopy assays
Infected cells were washed with PBS and visualized directly
for fluorescence derived from GFP expression. In immunofluo-
rescence assays, cells were fixed with 2% paraformaldehyde
(PFA) for 10 min in the dark and permeabilized with 0.5%
saponin for 10 min. Cell monolayers were labeled with SV5
anti-N monoclonal antibody D (kind gift of R. Randall;
University of St. Andrews) followed by a secondary AlexaFluor
488 goat anti-mouse IgG (Molecular Probes) and mounting
media containing DAPI. Samples were analyzed with the Nikon
Eclipse fluorescence microscope and a 20× lens. Images were
captured using a QImaging digital camera and processed using
QCapture software. Exposure times were manually set to be
constant between samples.Acknowledgments
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